Abstract
Purpose
Most site-specific cancer incidence is increased with the decrease of glomerular filtration rate (GFR). We analyzed endometrial cancers depending on different type, staging, and histology grades. We hypothesized that patients with lower GFR levels have an increased risk for higher staging and histology grades of endometrial cancers.
Methods
Patients were divided into two subgroups regarding GFR; the first group with GFR < 60 ml/min and the second group with GFR > 60 ml/min and regarding different histology grades and cancer stages. Cancers were also divided by stages (1–4). Patients were followed up during 1 year through regular controls in the outpatient clinic and during that time cancer recurrence was recorded.
Results
GFR was the strongest predictor for higher cancer histology grade and higher cancer staging. Patients with reduced GFR had OR for higher histology grade and higher staging of 1.06 and 1.06. Traditional risk factors for endometrial cancer development were not associated with higher histology grade or higher cancer staging.
Conclusion
Higher staging and histology grades in patients with endometrial cancers are associated with reduced GFR. Patients with mild-to-moderate CKD had significantly higher number of cancers with higher histology grades and higher stages than patients with mild or normal GFR category. Decline in GFR was independently associated with more aggressive cancers without other well-known risk factors for endometrial cancer development like age, menopause, diabetes, and obesity.
Similar content being viewed by others
References
Weng PH, Hung KY, Huang H et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6(5):1121–1128
Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an International Collaborative Study. Lancet 354:93–99
Cengiz K (2002) Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33:121–126
Dalrymple LS, Katz R, Kestenbaum B et al (2011) Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26(4):379–385
Iff S, Craig JC, Turner R et al (2014) Reduced estimated GFR and cancer mortality. Am J Kidney Dis 63(1):23–30
Fried LF, Katz R, Sarnak MJ et al (2005) Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16(12):3728–3735
Yang Y, Li H, Zhou Q et al (2016) Renal function and all-cause mortality risk among cancer patients. Medicine (Baltimore) 95(20):e3728
Kato S, Chmielewski M, Honda H et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526–1533
Reuter S, Gupta SC, Chaturvedi MM et al (2010) Oxidative stress, inflammation, and cancer. How are they linked? Free Radic Biol Med 49(11):1603–1616
Wilson WEC, Kirkpatrick CH, Talmage DW (1965) Suppression of immunologic responsiveness in uraemia. Ann Intern Med 62:1
Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831
Shebl FM, Warren JL, Eggers PW et al (2012) Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study. BMC Nephrol 13:65
Wong G, Staplin N, Emberson J et al (2016) Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer 16:488
Chang WF, Horng HC, Yeh CC et al (2018) Risk of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease. A population-based cohort study in Taiwan. Medicine (Baltimore) 97(12):e0157
Chavan DM, Huang Z, Song K et al (2017) Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer. Medicine (Baltimore) 96:e7935
Clarke-Pearson DL (2009) Clinical practice. Screening for ovarian cancer. N Engl J Med 361(2):170–177
Rule AD (2010) The CKD-EPI equation for estimating GFR from serum creatinine: real improvement or more of the same? Clin J Am Soc Nephrol 5:6951–6953
Creasman W (2009) Revised FIGO staging for carcinoma oft he endometrium. Int J Gynaecol Obstet 105(2):109
Kurman RJ, Carangin ML, Herrington CY et al (2014) WHO Classification of the tumors of the female reproductive organs. World Health Organisation, pp 126, 150
Salani R, Backes FJ, Fung MF et al (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologist recommendations. Am J Obstet Gynecol 204(6):466
Croatian Institute of Public Health (2016) The Croatian National Cancer Registry. Cancer incidence in Croatia for 2014. Bulletin No. 39
Donin NM, Suh LK, Barlow L et al (2012) Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma. BJU Int 109(3):379–383
Stengel B (2010) Chronic kidney disease and cancer: a troubling connection. J Nephrol 23(3):253–262
Izzedine H, Perazella MA (2015) Onco-nephrology: an appraisal of the cancer and chronic kidney disease links. Nephrol Dial Transplant 30(12):1979–1988
Luo F, Wang YS, Su YH et al (2017) Prognostic implications of preoperative anemia in urothelial carcinoma: a meta-analysis. PLoS One 12(2):e0171701
Premuzic V, Gamulin M, Coric M et al (2017) The incidence of urinary tract cancers is related to preserved diuresis: a single-center report. Int Urol Nephrol 49(12):2257–2263
Espersen T, Schmitz O, Hanse HE et al (1988) Ovulation in uremic women: the reproductive cycle in women on chronic hemodialysis. Int J Fertil 33(2):103–106
Zingraff J, Jungers P, Pelissier C et al (1982) Pituitary and ovarian dysfunctions in women on hemodialysis. Nephron 30(2):149–153
Ergeneli MH, Duran EH, Zeyneloglu HB et al (1999) Endometrial response to unopposed estrogens remains unaltered in patients with chronic renal failure receiving hemodialysis. Gynecol Obstet Invest 47(1):26–28
Fucic A, Gamulin M, Ferencic Z et al (2012) Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney pancreas, and brain. Environ Health 11(suppl 1):S8
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Premuzic, V., Kruezi, E., Berovic, M. et al. The association of the decline in glomerular filtration rate with aggressive endometrial cancers. Int Urol Nephrol 52, 161–168 (2020). https://doi.org/10.1007/s11255-019-02324-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-019-02324-w